WHAT IS GW 501516?
Cardarine activates AMP- activated protein kinase in the body and stimulates glucose uptake in skeletal muscle tissue. Cardarine has also been demonstrated to reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome. This is due to it stimulating fatty acid oxidation. It has been proposed as a potential treatment for obesity and related conditions.
HOW IT WORKS:
Cardarine has shown to regulate fat burning through a number of widespread mechanisms; it increases glucose uptake in the skeletal muscle tissue and aids in increasing muscle gene expression, especially the genes involved in preferential lipid utilization within the body. This, in turn, changes focus of the body’s metabolism to favor burning fat for energy instead of carbohydrates or muscle protein. This can potentially allow clinical application for obese patients to lose fat effectively without experiencing muscle catabolism or the effects and satiety issues associated with low blood sugar levels. It can also increase muscle mass.